AU
UK
CA
US
IND
NZ
Company Overview: 4DMedical Limited (ASX: 4DX) is a global medical technology company transforming lung function assessment in respiratory disease patients. Its patented XV Technology® enables precise analysis of regional airflow, allowing earlier and more accurate detection of respiratory issues. This technology powers the company’s FDA-cleared XV Lung Ventilation Analysis Software (XV LVAS®) and its Computed Tomography-enabled counterpart software, CT LVAS™. Kingsgate Consolidated Limited (ASX: KCN) is an Australian gold and silver producer, known for its Chatree Gold Mine in Thailand and the Nueva Esperanza Gold-Silver Project in Chile's Maricunga Belt. With extensive experience in gold exploration, development, and mining, Kingsgate is a key player in the Pacific Rim region. The company focuses on advancing its portfolio of high-quality, high-potential gold and silver assets. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
ASX All Ordinaries Index (.AORD) Market Round-Up
The ASX All Ordinaries Index (.AORD) ended the week modestly lower, closing at 8,954.60, down 2.30% for the period ending 6 February 2026. The decline was primarily driven by weakness in U.S. equity markets, which set a softer global tone and weighed on domestic investor sentiment. Ongoing external headwinds have reinforced a cautious near-term outlook for Australian equities heading into the week ahead.
From a technical perspective, the index is trading above a key falling trendline, signaling a renewed shift toward upward momentum. This breakout has converted the trendline into a firm support level, confirming the strength of the current bullish setup. Additionally, the index remains above its 50-period Simple Moving Average (SMA), reinforcing this zone as an important near-term support area that could continue to underpin further gains in the sessions ahead. The upcoming macroeconomic events that may impact the market sentiments include an update on the AU Westpac Consumer Sentiment, US ADP Non-Farm Employment Change, and US Unemployment Claims, etc., released weekly.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
This report (“Report”) has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this Report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine).
The information in this Report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its reports (including this Report), newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not issue, sell or deal in any financial products. The information in this Report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain general recommendations to invest in securities and other financial products. Kalkine is not responsible for, and does not guarantee, the performance of, or returns on, any investments mentioned in this Report.
This Report may contain information on past performance of particular investments. Past performance is not a reliable indicator of future performance. Returns stated do not take into account transaction costs and taxes.
Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Report, or its content, may be reproduced in any form without our prior consent.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...